Panacea Index Logo

Command Palette

Search for a command to run...

Different types of alcoholic beverages and incidence of metabolic syndrome and its components in a Mediterranean cohort.

Clinical nutrition (Edinburgh, Scotland)
October 1, 2013
Maria T Barrio-Lopez et al. (7 authors)
Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tHuman Study
Study Details

Study Goal

The researchers aimed to assess the association between alcohol consumption, including wine, and the incidence of Metabolic Syndrome (MS) in a Mediterranean cohort.

Results Summary

The study found no significant association between wine consumption and MS, unlike beer, which showed higher risks for MS and hypertriglyceridemia. Wine did not demonstrate adverse or beneficial effects on MS criteria in this study.

Population

8,103 university graduates (mean age 35.4 years) initially free of MS criteria.

Effective Dosage

≥7 drinks/week (general alcohol consumption; wine-specific dosage not detailed).

Duration

≥6 years of follow-up.

Interactions

None mentioned.

Extracted Claims (9)
InterventionDirectionEndpointPopulationDosageImpactClaim #
alcohol consumption (≥7 drinks/wk)
increase
developing Metabolic Syndrome (MS)
University graduates free of any MS criteria
aOR: 1.80; 95% CI: 1.22-2.66; p < 0.001
presented a significantly higher risk
#1
alcohol consumption (≥7 drinks/wk)
increase
hypertriglyceridemia
University graduates free of any MS criteria
aOR: 2.07; 95% CI: 1.46-2.93
had higher risk
#2
alcohol consumption (≥7 drinks/wk)
increase
impaired fasting glucose
University graduates free of any MS criteria
aOR: 1.54; 95% CI: 1.16-2.04
had higher risk
#3
beer consumption (≥7 drinks/wk)
increase
Metabolic Syndrome (MS)
University graduates free of any MS criteria
p for trend = 0.027
was associated with higher risk
#4
beer consumption (≥7 drinks/wk)
increase
hypertriglyceridemia
University graduates free of any MS criteria
aOR: 1.81; 95% CI: 1.02-3.20
was associated with higher risk
#5
beer consumption (≥7 drinks/wk)
decrease
low HDL-cholesterol criterion
University graduates free of any MS criteria
aOR: 0.21; 95% CI: 0.05-0.89
was associated with lower risk
#6
wine consumption
no change
Metabolic Syndrome (MS)
University graduates free of any MS criteria
-
Non-significant association was observed
#7
liquor consumption
no change
Metabolic Syndrome (MS)
University graduates free of any MS criteria
-
Non-significant association was observed
#8
Consumption of at least seven alcoholic drinks per week
increase
developing Metabolic Syndrome (MS)
subjects initially free of any MS criteria
-
was associated with a higher risk
#9
Abstract

BACKGROUND & AIMS: We prospectively assessed the association between alcohol consumption and the incidence of Metabolic Syndrome (MS) in a Mediterranean cohort. METHODS: We included 8103 (mean age: 35.4 years) University graduates free of any MS criteria and followed-up during ≥6 years. Alcohol consumption was collected with a validated 136-item food frequency questionnaire. New-onset cases of MS were defined according to the updated harmonizing criteria. RESULTS: We observed 341 incident cases of MS. Consumers of ≥7 drinks/wk presented a significantly higher risk of developing MS (aOR: 1.80; 95% CI: 1.22-2.66; p < 0.001) compared with non-drinkers. In addition, alcohol drinkers (≥7 drinks/wk) had higher risk of hypertriglyceridemia (aOR: 2.07; 95% CI: 1.46-2.93) and impaired fasting glucose (aOR: 1.54; 95% CI: 1.16-2.04). Beer consumption was associated with higher risk for MS (p for trend = 0.027) and higher risk of hypertriglyceridemia (aOR: 1.81; 95% CI: 1.02-3.20), but with lower risk of low HDL-cholesterol criterion (aOR: 0.21; 95% CI: 0.05-0.89) for ≥7 drinks/wk versus no consumption. Non-significant association was observed between wine or liquor consumption and MS. CONCLUSIONS: Consumption of at least seven alcoholic drinks per week was associated with a higher risk of developing MS among subjects initially free of any MS criteria.

Medical Subject Headings (MeSH)
AdultAlcoholic BeveragesCholesterol, HDLCohort StudiesDietFemaleFollow-Up StudiesGlucose IntoleranceHumansHypertriglyceridemiaHypoalphalipoproteinemiasIncidenceLost to Follow-UpMaleMetabolic SyndromePrediabetic StateProspective StudiesRisk FactorsSpainSurveys and Questionnaires
Study Links
Quality Scores
SafetyNot Assessed
Efficacy50/10
Quality85/10
Citation Metrics
Total Citations27
Citations/Year2.3
Relative Citation Ratio1.09
NIH Percentile53.4%
Research Impact Scores
APT Score0.75
Weight Score10.97
Normalized Score0.57
Related Supplements